Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
February 19, 2026
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2021 Results and Provides Business Update
November 12, 2021
Related Post
-
-
Outlook Therapeutics Expands European Footprint with Exclusive Commercial Distribution Agreement with Mediconsult AG for LYTENAVA(TM) (bevacizumab gamma) in Switzerland
February 19, 2026
-
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
-
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
February 19, 2026